Literature DB >> 21053927

Identification of quinone imine containing glutathione conjugates of diclofenac in rat bile.

Daniel J Waldon1, Yohannes Teffera, Adria E Colletti, Jingzhou Liu, Danielle Zurcher, Katrina W Copeland, Zhiyang Zhao.   

Abstract

High-resolution accurate MS with an LTQ-Orbitrap was used to identify quinone imine metabolites derived from the 5-hydroxy (5-OH) and 4 prime-hydroxy (4'-OH) glutathione conjugates of diclofenac in rat bile. The initial quinone imine metabolites formed by oxidation of diclofenac have been postulated to be reactive intermediates potentially involved in diclofenac-mediated hepatotoxicity; while these metabolites could be formed using in vitro systems, they have never been detected in vivo. This report describes the identification of secondary quinone imine metabolites derived from 5-OH and 4'-OH diclofenac glutathione conjugates in rat bile. To verify the proposed structures, the diclofenac quinone imine GSH conjugate standards were prepared synthetically and enzymatically. The novel metabolite peaks displayed the identical retention times, accurate mass MS/MS spectra, and the fragmentation patterns as the corresponding authentic standards. The formation of these secondary quinone metabolites occurs only under conditions where bile salt homeostasis was experimentally altered. Standard practice in biliary excretion experiments using bile duct-cannulated rats includes infusion of taurocholic acid and/or other bile acids to replace those lost due to continuous collection of bile; for this experiment, the rats received no replacement bile acid infusion. High-resolution accurate mass spectrometry data and comparison with chemically and enzymatically prepared quinone imines of diclofenac glutathione conjugates support the identification of these metabolites. A mechanism for the formation of these reactive quinone imine containing glutathione conjugates of diclofenac is proposed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21053927     DOI: 10.1021/tx100296v

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  8 in total

1.  Covalent protein binding and tissue distribution of houttuynin in rats after intravenous administration of sodium houttuyfonate.

Authors:  Zhi-peng Deng; Da-fang Zhong; Jian Meng; Xiao-yan Chen
Journal:  Acta Pharmacol Sin       Date:  2012-03-05       Impact factor: 6.150

2.  Preparative microfluidic electrosynthesis of drug metabolites.

Authors:  Romain Stalder; Gregory P Roth
Journal:  ACS Med Chem Lett       Date:  2013-10-01       Impact factor: 4.345

3.  Identification and Characterization of Efflux Transporters That Modulate the Subtoxic Disposition of Diclofenac and Its Metabolites.

Authors:  Renato J Scialis; Lauren M Aleksunes; Iván L Csanaky; Curtis D Klaassen; José E Manautou
Journal:  Drug Metab Dispos       Date:  2019-08-09       Impact factor: 3.922

4.  Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach.

Authors:  Ali S Abdelhameed; Mohamed W Attwa; Adnan A Kadi
Journal:  Drug Des Devel Ther       Date:  2020-11-30       Impact factor: 4.162

5.  Potential protective effect of sunitinib after administration of diclofenac: biochemical and histopathological drug-drug interaction assessment in a mouse model.

Authors:  Jian Ren Tan; Srikumar Chakravarthi; John Paul Judson; Nagaraja Haleagrahara; Ignacio Segarra
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-05       Impact factor: 3.000

6.  Bioactivation of the cancer chemopreventive agent tamoxifen to quinone methides by cytochrome P4502B6 and identification of the modified residue on the apoprotein.

Authors:  Chitra Sridar; Jaime D'Agostino; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2012-08-31       Impact factor: 3.922

7.  Impacts of diphenylamine NSAID halogenation on bioactivation risks.

Authors:  Mary Alexandra Schleiff; Sasin Payakachat; Benjamin Mark Schleiff; S Joshua Swamidass; Gunnar Boysen; Grover Paul Miller
Journal:  Toxicology       Date:  2021-06-06       Impact factor: 4.571

8.  Phase I metabolic profiling and unexpected reactive metabolites in human liver microsome incubations of X-376 using LC-MS/MS: bioactivation pathway elucidation and in silico toxicity studies of its metabolites.

Authors:  Mohamed W Attwa; Adnan A Kadi; Ali S Abdelhameed
Journal:  RSC Adv       Date:  2020-02-03       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.